Arboreal Bioinnovations raises Rs 230 Cr in Series A round co-led by EAAA and Omnivore

Summary

Arboreal Bioinnovations raised Rs 230 Cr in a Series A round co-led by EAAA and Omnivore to expand manufacturing capacity, strengthen R&D, and accelerate commercialization.

Why it matters

• Bio-based manufacturing can scale into a serious category when it replaces expensive or carbon-heavy inputs with a repeatable process.
• The round shows patient capital is still available for science-backed businesses that can convert lab progress into industrial output.

Founder/operator read

• Manufacturing scale, quality systems, and commercial repeatability matter as much as the science itself.
• If you are building in industrial biotech, your investor story should include throughput, margins, and customer adoption alongside R&D.

Original source

Read original